Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines

Back Print
Agency:
State: South Carolina
Level of Government: Federal
Category:
  • A - Research and development
Opps ID: NBD00159368645586296
Posted Date: Jan 22, 2024
Due Date: Mar 15, 2024
Source: Members Only
Follow
Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines
Active
Contract Opportunity
Notice ID
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
BARDA - ASPR / DAAPPO / BARDA DCMA
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Jan 22, 2024 01:12 pm EST
  • Original Response Date: Mar 15, 2024 01:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Mar 30, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:
    Summerville , SC
    USA
Description

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA), titled, "Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines."



The full RPP as well as information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.


Attachments/Links
Contact Information
Contracting Office Address
  • O’NEILL HOUSE OFFICE BUILDING
  • WASHINGTON , DC 20515
  • USA
Primary Point of Contact


Secondary Point of Contact


History
  • Jan 22, 2024 01:12 pm ESTSpecial Notice (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >